{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"231"},{"groupId":"OG001","value":"87"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"321"},{"groupId":"OG001","value":"321"}],"units":"Participants"}],"description":"Applied to use of the intervention (number of lozenges/day or number of patches used per week) not considering abstinence","groups":[{"description":"Participants apply a transdermal nicotine patch at 3 different time periods during weeks 3-14; a higher-dose patch is applied for weeks 3-8, a medium-dose patch is applied for weeks 9-10, and a lower-dose patch is applied for weeks 11-14.","id":"OG000","title":"Arm I"},{"description":"Participants receive one oral nicotine lozenge every 1-2 hours in weeks 3-8 (≥ 9 lozenges per day), one lozenge every 2-4 hours in weeks 9-11 (≥ 5 lozenges per day), and 1 lozenge every 4-8 hours in weeks 12-14 (≥ 3 lozenges per day).","id":"OG001","title":"Arm II"}],"paramType":"NUMBER","populationDescription":"Intent to treat","reportingStatus":"POSTED","timeFrame":"2 weeks","title":"Rate of Compliance During the First 2 Weeks","type":"SECONDARY","unitOfMeasure":"participants"}